Table 2: Basic clinical and biochemical characteristics by quartiles of CA19-9.

Variables CA19-9 quartile 𝑃 value
1 (Lowest)234 (Highest)

Age (y) 5 6 . 6 4 ± 1 2 . 1 9 8 6 0 . 1 ± 1 2 . 6 5 2 * 5 8 . 7 5 ± 1 3 . 5 3 4 5 8 . 2 1 ± 1 3 . 8 0 6 0.023
Duration (y)8.0 (3.0–12.0)9.0 (4.0–12.5)8.0 (3.0–13.0)8.0 (3.0–13.0)0.327
ALT (U/L)17.00 (13.00–26.00)19.00 (13.75–30.00)17.00 (13.00–75.00)19.00 (12.00–29.00)0.398
AST (U/L)19.00 (15.00–24.00)19.00 (16.00–24.75)18.50 (16.00–24.00)19.00 (16.00–25.00)0.508
TC (mmol/L) 4 . 6 6 ± 0 . 9 3 5 4 . 6 2 ± 1 . 0 5 4 4 . 7 5 ± 1 . 2 0 1 4 . 9 9 ± 1 . 3 6 7 **##▲0.001
TG (mmol/L)1.45 (0.99–2.08)1.43 (1.04–2.04)1.47 (0.93–2.07)1.44 (0.97–2.21)0.739
HDL (mmol/L) 1 . 1 8 ± 0 . 4 2 8 1 . 1 2 ± 0 . 3 2 6 * 1 . 1 5 ± 0 . 3 2 8 1 . 1 8 ± 0 . 3 6 8 0.167
LDL (mmol/L) 3 . 1 1 ± 0 . 8 4 9 3 . 1 0 ± 0 . 9 1 4 3 . 1 6 ± 1 . 0 3 2 3 . 2 7 ± 1 . 0 8 6 0.168
BUN (mmol/L) 5 . 3 7 ± 1 . 6 1 5 5 . 8 4 ± 2 . 5 1 7 5 . 7 5 ± 2 . 3 4 0 5 . 9 1 ± 2 . 9 3 1 0.056
Cr (μmol/L)67.00 (57.00–78.25)68.00 (57.00–81.00)64.00 (54.00–77.00)63.00 (51.75–80.50)0.363
FPG (mmol/L) 6 . 8 4 ± 2 . 3 6 7 7 . 9 3 ± 2 . 7 5 2 ** 8 . 7 3 ± 3 . 2 6 3 **# 9 . 1 5 ± 4 . 1 1 6 **##<0.001
2hPG (mmol/L) 1 0 . 7 7 ± 4 . 7 0 1 3 . 7 2 ± 4 . 8 1 2 ** 1 3 . 9 5 ± 5 . 2 8 5 ** 1 4 . 7 2 ± 5 . 4 7 1 **<0.001
HbA1c (%) 7 . 3 6 ± 1 . 8 7 0 8 . 4 1 ± 1 . 9 4 5 ** 9 . 4 3 ± 2 . 4 4 4 **## 1 0 . 4 9 ± 2 . 7 6 8 **##▲▲<0.001
GA (%) 2 1 . 8 9 ± 5 . 8 7 4 2 4 . 3 0 ± 6 . 8 1 9 * 2 7 . 1 8 ± 8 . 4 5 5 **## 3 0 . 2 9 ± 9 . 5 2 5 **##▲▲<0.001
CP0 (ng/mL)2.195 (1.383–4.228)1.80 (1.18–2.695)*1.705 (1.04–2.553)**1.29 (0.64–2.03)**#<0.001
CP120 (ng/mL)5.32 (2.85–15.05)4.21 (2.53–5.82)**3.27 (1.76–5.44)**#2.38 (1.31–4.15)**#<0.001
Δ CP (ng/mL)2.76 (1.34–9.388)2.09 (0.94–3.41)**1.55 (0.53–2.77)**#1.00 (0.41–2.06)**#▲<0.001

Data represent means ± S.D. or median (interquartile range), * 𝑃 < 0 . 0 5 , ** 𝑃 < 0 . 0 1 versus group 1; # 𝑃 < 0 . 0 5 ,  ## 𝑃 < 0 . 0 1 versus proup 2; 𝑃 < 0 . 0 5 ,  ▲▲ 𝑃 < 0 . 0 1 versus proup 3.